Global Iruplinac Tablets Market Growth 2026-2032
The global Iruplinac Tablets market size is predicted to grow from US$ 16.83 million in 2025 to US$ 58.16 million in 2032; it is expected to grow at a CAGR of 9.2% from 2026 to 2032.
Iruplinalkib is a new-generation selective RET tyrosine kinase inhibitor independently developed in China. Targeting RET fusions and RET mutations, it is mainly applied in the clinical treatment of locally advanced or metastatic non-small cell lung cancer, medullary thyroid carcinoma and other malignant tumors with positive RET fusion after prior treatment. By specifically inhibiting the abnormal activation of the RET kinase signaling pathway, the drug blocks the proliferation, invasion and metastasis of tumor cells. Featuring high target selectivity, favorable safety and independent domestic innovation advantages, it optimizes the precise treatment regimens for tumors with RET alterations. Currently included in the national medical insurance catalog, it is widely used in clinical oncology treatment across China.In 2025, global Iruplinalkib production reached approximately 107,000 bottles.
As a highly selective RET inhibitor independently developed in China, Iruplinalkib boasts significant market competitiveness in the treatment of RET fusion-positive tumors. Driven by the ?? rising demand for precision medicine, expanding national medical insurance coverage and growing clinical recognition in China, its market penetration has advanced steadily. Compared with imported drugs of the same class, Iruplinalkib holds a key position in indications such as advanced non-small cell lung cancer and medullary thyroid carcinoma, supported by clinical data better tailored to Chinese patients, favorable safety and accessibility advantages. While competition in the RET targeted therapy space is intensifying, the product continues to consolidate its clinical and market position through differentiated efficacy and domestic innovation attributes. It is expected to further unlock growth potential via indication expansion, channel penetration and overseas market layout in the future.
LP Information, Inc. (LPI) ' newest research report, the ?Iruplinac Tablets Industry Forecast? looks at past sales and reviews total world Iruplinac Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Iruplinac Tablets sales for 2026 through 2032. With Iruplinac Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iruplinac Tablets industry.
This Insight Report provides a comprehensive analysis of the global Iruplinac Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iruplinac Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Iruplinac Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iruplinac Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iruplinac Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Iruplinac Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Iruplinac Tablets market?
What factors are driving Iruplinac Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iruplinac Tablets market opportunities vary by end market size?
How does Iruplinac Tablets break out by Type, by Application?
Iruplinalkib is a new-generation selective RET tyrosine kinase inhibitor independently developed in China. Targeting RET fusions and RET mutations, it is mainly applied in the clinical treatment of locally advanced or metastatic non-small cell lung cancer, medullary thyroid carcinoma and other malignant tumors with positive RET fusion after prior treatment. By specifically inhibiting the abnormal activation of the RET kinase signaling pathway, the drug blocks the proliferation, invasion and metastasis of tumor cells. Featuring high target selectivity, favorable safety and independent domestic innovation advantages, it optimizes the precise treatment regimens for tumors with RET alterations. Currently included in the national medical insurance catalog, it is widely used in clinical oncology treatment across China.In 2025, global Iruplinalkib production reached approximately 107,000 bottles.
As a highly selective RET inhibitor independently developed in China, Iruplinalkib boasts significant market competitiveness in the treatment of RET fusion-positive tumors. Driven by the ?? rising demand for precision medicine, expanding national medical insurance coverage and growing clinical recognition in China, its market penetration has advanced steadily. Compared with imported drugs of the same class, Iruplinalkib holds a key position in indications such as advanced non-small cell lung cancer and medullary thyroid carcinoma, supported by clinical data better tailored to Chinese patients, favorable safety and accessibility advantages. While competition in the RET targeted therapy space is intensifying, the product continues to consolidate its clinical and market position through differentiated efficacy and domestic innovation attributes. It is expected to further unlock growth potential via indication expansion, channel penetration and overseas market layout in the future.
LP Information, Inc. (LPI) ' newest research report, the ?Iruplinac Tablets Industry Forecast? looks at past sales and reviews total world Iruplinac Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Iruplinac Tablets sales for 2026 through 2032. With Iruplinac Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iruplinac Tablets industry.
This Insight Report provides a comprehensive analysis of the global Iruplinac Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iruplinac Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Iruplinac Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iruplinac Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iruplinac Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Iruplinac Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30 mg / tablet
- 60 mg / tablet
- Iruplinalkib Combined With Cabozantinib
- Iruplinalkib Combined With Pralsetinib
- Hospital
- Retail
- Online
- Non-Small Cell Lung Cancer
- Medullary Thyroid Carcinoma
- Differentiated Thyroid Carcinoma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qilu Pharmaceutical
What is the 10-year outlook for the global Iruplinac Tablets market?
What factors are driving Iruplinac Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iruplinac Tablets market opportunities vary by end market size?
How does Iruplinac Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Iruplinac Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Iruplinac Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Iruplinac Tablets by Country/Region, 2021, 2025 & 2032
2.2 Iruplinac Tablets Segment by Type
2.2.1 30 mg / tablet
2.2.2 60 mg / tablet
2.2.3 Iruplinac Tablets Sales by Type
2.2.3.1 Global Iruplinac Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Iruplinac Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Iruplinac Tablets Sale Price by Type (2021-2026)
2.3 Iruplinac Tablets Segment by Combination Therapy
2.3.1 Iruplinalkib Combined With Cabozantinib
2.3.2 Iruplinalkib Combined With Pralsetinib
2.3.3 Iruplinac Tablets Sales by Combination Therapy
2.3.3.1 Global Iruplinac Tablets Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Iruplinac Tablets Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Iruplinac Tablets Sale Price by Combination Therapy (2021-2026)
2.4 Iruplinac Tablets Segment by Sales Channel
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Iruplinac Tablets Sales by Sales Channel
2.4.4.1 Global Iruplinac Tablets Sales Market Share by Sales Channel (2021-2026)
2.4.4.2 Global Iruplinac Tablets Revenue and Market Share by Sales Channel (2021-2026)
2.4.4.3 Global Iruplinac Tablets Sale Price by Sales Channel (2021-2026)
2.5 Iruplinac Tablets Segment by Application
2.5.1 Non-Small Cell Lung Cancer
2.5.2 Medullary Thyroid Carcinoma
2.5.3 Differentiated Thyroid Carcinoma
2.5.4 Others
2.5.5 Iruplinac Tablets Sales by Application
2.5.5.1 Global Iruplinac Tablets Sale Market Share by Application (2021-2026)
2.5.5.2 Global Iruplinac Tablets Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Iruplinac Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Iruplinac Tablets Breakdown Data by Company
3.1.1 Global Iruplinac Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Iruplinac Tablets Sales Market Share by Company (2021-2026)
3.2 Global Iruplinac Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Iruplinac Tablets Revenue by Company (2021-2026)
3.2.2 Global Iruplinac Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Iruplinac Tablets Sale Price by Company
3.4 Key Manufacturers Iruplinac Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iruplinac Tablets Product Location Distribution
3.4.2 Players Iruplinac Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IRUPLINAC TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Iruplinac Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Iruplinac Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Iruplinac Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Iruplinac Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Iruplinac Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Iruplinac Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Iruplinac Tablets Sales Growth
4.4 APAC Iruplinac Tablets Sales Growth
4.5 Europe Iruplinac Tablets Sales Growth
4.6 Middle East & Africa Iruplinac Tablets Sales Growth
5 AMERICAS
5.1 Americas Iruplinac Tablets Sales by Country
5.1.1 Americas Iruplinac Tablets Sales by Country (2021-2026)
5.1.2 Americas Iruplinac Tablets Revenue by Country (2021-2026)
5.2 Americas Iruplinac Tablets Sales by Type (2021-2026)
5.3 Americas Iruplinac Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iruplinac Tablets Sales by Region
6.1.1 APAC Iruplinac Tablets Sales by Region (2021-2026)
6.1.2 APAC Iruplinac Tablets Revenue by Region (2021-2026)
6.2 APAC Iruplinac Tablets Sales by Type (2021-2026)
6.3 APAC Iruplinac Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Iruplinac Tablets by Country
7.1.1 Europe Iruplinac Tablets Sales by Country (2021-2026)
7.1.2 Europe Iruplinac Tablets Revenue by Country (2021-2026)
7.2 Europe Iruplinac Tablets Sales by Type (2021-2026)
7.3 Europe Iruplinac Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Iruplinac Tablets by Country
8.1.1 Middle East & Africa Iruplinac Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Iruplinac Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Iruplinac Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Iruplinac Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iruplinac Tablets
10.3 Manufacturing Process Analysis of Iruplinac Tablets
10.4 Industry Chain Structure of Iruplinac Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iruplinac Tablets Distributors
11.3 Iruplinac Tablets Customer
12 WORLD FORECAST REVIEW FOR IRUPLINAC TABLETS BY GEOGRAPHIC REGION
12.1 Global Iruplinac Tablets Market Size Forecast by Region
12.1.1 Global Iruplinac Tablets Forecast by Region (2027-2032)
12.1.2 Global Iruplinac Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Iruplinac Tablets Forecast by Type (2027-2032)
12.7 Global Iruplinac Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Iruplinac Tablets Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Iruplinac Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Iruplinac Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Iruplinac Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Iruplinac Tablets by Country/Region, 2021, 2025 & 2032
2.2 Iruplinac Tablets Segment by Type
2.2.1 30 mg / tablet
2.2.2 60 mg / tablet
2.2.3 Iruplinac Tablets Sales by Type
2.2.3.1 Global Iruplinac Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Iruplinac Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Iruplinac Tablets Sale Price by Type (2021-2026)
2.3 Iruplinac Tablets Segment by Combination Therapy
2.3.1 Iruplinalkib Combined With Cabozantinib
2.3.2 Iruplinalkib Combined With Pralsetinib
2.3.3 Iruplinac Tablets Sales by Combination Therapy
2.3.3.1 Global Iruplinac Tablets Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Iruplinac Tablets Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Iruplinac Tablets Sale Price by Combination Therapy (2021-2026)
2.4 Iruplinac Tablets Segment by Sales Channel
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Iruplinac Tablets Sales by Sales Channel
2.4.4.1 Global Iruplinac Tablets Sales Market Share by Sales Channel (2021-2026)
2.4.4.2 Global Iruplinac Tablets Revenue and Market Share by Sales Channel (2021-2026)
2.4.4.3 Global Iruplinac Tablets Sale Price by Sales Channel (2021-2026)
2.5 Iruplinac Tablets Segment by Application
2.5.1 Non-Small Cell Lung Cancer
2.5.2 Medullary Thyroid Carcinoma
2.5.3 Differentiated Thyroid Carcinoma
2.5.4 Others
2.5.5 Iruplinac Tablets Sales by Application
2.5.5.1 Global Iruplinac Tablets Sale Market Share by Application (2021-2026)
2.5.5.2 Global Iruplinac Tablets Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Iruplinac Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Iruplinac Tablets Breakdown Data by Company
3.1.1 Global Iruplinac Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Iruplinac Tablets Sales Market Share by Company (2021-2026)
3.2 Global Iruplinac Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Iruplinac Tablets Revenue by Company (2021-2026)
3.2.2 Global Iruplinac Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Iruplinac Tablets Sale Price by Company
3.4 Key Manufacturers Iruplinac Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iruplinac Tablets Product Location Distribution
3.4.2 Players Iruplinac Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IRUPLINAC TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Iruplinac Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Iruplinac Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Iruplinac Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Iruplinac Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Iruplinac Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Iruplinac Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Iruplinac Tablets Sales Growth
4.4 APAC Iruplinac Tablets Sales Growth
4.5 Europe Iruplinac Tablets Sales Growth
4.6 Middle East & Africa Iruplinac Tablets Sales Growth
5 AMERICAS
5.1 Americas Iruplinac Tablets Sales by Country
5.1.1 Americas Iruplinac Tablets Sales by Country (2021-2026)
5.1.2 Americas Iruplinac Tablets Revenue by Country (2021-2026)
5.2 Americas Iruplinac Tablets Sales by Type (2021-2026)
5.3 Americas Iruplinac Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iruplinac Tablets Sales by Region
6.1.1 APAC Iruplinac Tablets Sales by Region (2021-2026)
6.1.2 APAC Iruplinac Tablets Revenue by Region (2021-2026)
6.2 APAC Iruplinac Tablets Sales by Type (2021-2026)
6.3 APAC Iruplinac Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Iruplinac Tablets by Country
7.1.1 Europe Iruplinac Tablets Sales by Country (2021-2026)
7.1.2 Europe Iruplinac Tablets Revenue by Country (2021-2026)
7.2 Europe Iruplinac Tablets Sales by Type (2021-2026)
7.3 Europe Iruplinac Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Iruplinac Tablets by Country
8.1.1 Middle East & Africa Iruplinac Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Iruplinac Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Iruplinac Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Iruplinac Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iruplinac Tablets
10.3 Manufacturing Process Analysis of Iruplinac Tablets
10.4 Industry Chain Structure of Iruplinac Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iruplinac Tablets Distributors
11.3 Iruplinac Tablets Customer
12 WORLD FORECAST REVIEW FOR IRUPLINAC TABLETS BY GEOGRAPHIC REGION
12.1 Global Iruplinac Tablets Market Size Forecast by Region
12.1.1 Global Iruplinac Tablets Forecast by Region (2027-2032)
12.1.2 Global Iruplinac Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Iruplinac Tablets Forecast by Type (2027-2032)
12.7 Global Iruplinac Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Iruplinac Tablets Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Iruplinac Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IruplinacTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IruplinacTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg / tablet
Table 4. Major Players of 60 mg / tablet
Table 5. Global IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 6. Global IruplinacTablets Sales Market Share by Type (2021-2026)
Table 7. Global IruplinacTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global IruplinacTablets Revenue Market Share by Type (2021-2026)
Table 9. Global IruplinacTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Iruplinalkib Combined With Cabozantinib
Table 11. Major Players of Iruplinalkib Combined With Pralsetinib
Table 12. Global IruplinacTablets Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global IruplinacTablets Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global IruplinacTablets Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global IruplinacTablets Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global IruplinacTablets Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global IruplinacTablets Sales by Sales Channel (2021-2026) & (Units)
Table 21. Global IruplinacTablets Sales Market Share by Sales Channel (2021-2026)
Table 22. Global IruplinacTablets Revenue by Sales Channel (2021-2026) & ($ million)
Table 23. Global IruplinacTablets Revenue Market Share by Sales Channel (2021-2026)
Table 24. Global IruplinacTablets Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 25. Global IruplinacTablets Sale by Application (2021-2026) & (Units)
Table 26. Global IruplinacTablets Sale Market Share by Application (2021-2026)
Table 27. Global IruplinacTablets Revenue by Application (2021-2026) & ($ million)
Table 28. Global IruplinacTablets Revenue Market Share by Application (2021-2026)
Table 29. Global IruplinacTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global IruplinacTablets Sales by Company (2021-2026) & (Units)
Table 31. Global IruplinacTablets Sales Market Share by Company (2021-2026)
Table 32. Global IruplinacTablets Revenue by Company (2021-2026) & ($ millions)
Table 33. Global IruplinacTablets Revenue Market Share by Company (2021-2026)
Table 34. Global IruplinacTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers IruplinacTablets Producing Area Distribution and Sales Area
Table 36. Players IruplinacTablets Products Offered
Table 37. IruplinacTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global IruplinacTablets Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global IruplinacTablets Sales Market Share Geographic Region (2021-2026)
Table 42. Global IruplinacTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global IruplinacTablets Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global IruplinacTablets Sales by Country/Region (2021-2026) & (Units)
Table 45. Global IruplinacTablets Sales Market Share by Country/Region (2021-2026)
Table 46. Global IruplinacTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global IruplinacTablets Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 49. Americas IruplinacTablets Sales Market Share by Country (2021-2026)
Table 50. Americas IruplinacTablets Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 52. Americas IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 53. APAC IruplinacTablets Sales by Region (2021-2026) & (Units)
Table 54. APAC IruplinacTablets Sales Market Share by Region (2021-2026)
Table 55. APAC IruplinacTablets Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 57. APAC IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 58. Europe IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 59. Europe IruplinacTablets Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 61. Europe IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa IruplinacTablets Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of IruplinacTablets
Table 67. Key Market Challenges & Risks of IruplinacTablets
Table 68. Key Industry Trends of IruplinacTablets
Table 69. IruplinacTablets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. IruplinacTablets Distributors List
Table 72. IruplinacTablets Customer List
Table 73. Global IruplinacTablets Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global IruplinacTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas IruplinacTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC IruplinacTablets Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC IruplinacTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe IruplinacTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa IruplinacTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global IruplinacTablets Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global IruplinacTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global IruplinacTablets Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global IruplinacTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Qilu Pharmaceutical Basic Information, IruplinacTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Qilu Pharmaceutical IruplinacTablets Product Portfolios and Specifications
Table 89. Qilu Pharmaceutical IruplinacTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Qilu Pharmaceutical Main Business
Table 91. Qilu Pharmaceutical Latest Developments
Table 1. IruplinacTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IruplinacTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg / tablet
Table 4. Major Players of 60 mg / tablet
Table 5. Global IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 6. Global IruplinacTablets Sales Market Share by Type (2021-2026)
Table 7. Global IruplinacTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global IruplinacTablets Revenue Market Share by Type (2021-2026)
Table 9. Global IruplinacTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Iruplinalkib Combined With Cabozantinib
Table 11. Major Players of Iruplinalkib Combined With Pralsetinib
Table 12. Global IruplinacTablets Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global IruplinacTablets Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global IruplinacTablets Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global IruplinacTablets Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global IruplinacTablets Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global IruplinacTablets Sales by Sales Channel (2021-2026) & (Units)
Table 21. Global IruplinacTablets Sales Market Share by Sales Channel (2021-2026)
Table 22. Global IruplinacTablets Revenue by Sales Channel (2021-2026) & ($ million)
Table 23. Global IruplinacTablets Revenue Market Share by Sales Channel (2021-2026)
Table 24. Global IruplinacTablets Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 25. Global IruplinacTablets Sale by Application (2021-2026) & (Units)
Table 26. Global IruplinacTablets Sale Market Share by Application (2021-2026)
Table 27. Global IruplinacTablets Revenue by Application (2021-2026) & ($ million)
Table 28. Global IruplinacTablets Revenue Market Share by Application (2021-2026)
Table 29. Global IruplinacTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global IruplinacTablets Sales by Company (2021-2026) & (Units)
Table 31. Global IruplinacTablets Sales Market Share by Company (2021-2026)
Table 32. Global IruplinacTablets Revenue by Company (2021-2026) & ($ millions)
Table 33. Global IruplinacTablets Revenue Market Share by Company (2021-2026)
Table 34. Global IruplinacTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers IruplinacTablets Producing Area Distribution and Sales Area
Table 36. Players IruplinacTablets Products Offered
Table 37. IruplinacTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global IruplinacTablets Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global IruplinacTablets Sales Market Share Geographic Region (2021-2026)
Table 42. Global IruplinacTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global IruplinacTablets Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global IruplinacTablets Sales by Country/Region (2021-2026) & (Units)
Table 45. Global IruplinacTablets Sales Market Share by Country/Region (2021-2026)
Table 46. Global IruplinacTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global IruplinacTablets Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 49. Americas IruplinacTablets Sales Market Share by Country (2021-2026)
Table 50. Americas IruplinacTablets Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 52. Americas IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 53. APAC IruplinacTablets Sales by Region (2021-2026) & (Units)
Table 54. APAC IruplinacTablets Sales Market Share by Region (2021-2026)
Table 55. APAC IruplinacTablets Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 57. APAC IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 58. Europe IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 59. Europe IruplinacTablets Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 61. Europe IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa IruplinacTablets Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa IruplinacTablets Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa IruplinacTablets Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa IruplinacTablets Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of IruplinacTablets
Table 67. Key Market Challenges & Risks of IruplinacTablets
Table 68. Key Industry Trends of IruplinacTablets
Table 69. IruplinacTablets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. IruplinacTablets Distributors List
Table 72. IruplinacTablets Customer List
Table 73. Global IruplinacTablets Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global IruplinacTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas IruplinacTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC IruplinacTablets Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC IruplinacTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe IruplinacTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa IruplinacTablets Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa IruplinacTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global IruplinacTablets Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global IruplinacTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global IruplinacTablets Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global IruplinacTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Qilu Pharmaceutical Basic Information, IruplinacTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Qilu Pharmaceutical IruplinacTablets Product Portfolios and Specifications
Table 89. Qilu Pharmaceutical IruplinacTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Qilu Pharmaceutical Main Business
Table 91. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of IruplinacTablets
Figure 2. IruplinacTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IruplinacTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global IruplinacTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IruplinacTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IruplinacTablets Sales Market Share by Country/Region (2025)
Figure 10. IruplinacTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg / tablet
Figure 12. Product Picture of 60 mg / tablet
Figure 13. Global IruplinacTablets Sales Market Share by Type in 2026
Figure 14. Global IruplinacTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Iruplinalkib Combined With Cabozantinib
Figure 16. Product Picture of Iruplinalkib Combined With Pralsetinib
Figure 17. Global IruplinacTablets Sales Market Share by Combination Therapy in 2026
Figure 18. Global IruplinacTablets Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global IruplinacTablets Sales Market Share by Sales Channel in 2026
Figure 23. Global IruplinacTablets Revenue Market Share by Sales Channel (2021-2026)
Figure 24. IruplinacTablets Consumed in Non-Small Cell Lung Cancer
Figure 25. Global IruplinacTablets Market: Non-Small Cell Lung Cancer (2021-2026) & (Units)
Figure 26. IruplinacTablets Consumed in Medullary Thyroid Carcinoma
Figure 27. Global IruplinacTablets Market: Medullary Thyroid Carcinoma (2021-2026) & (Units)
Figure 28. IruplinacTablets Consumed in Differentiated Thyroid Carcinoma
Figure 29. Global IruplinacTablets Market: Differentiated Thyroid Carcinoma (2021-2026) & (Units)
Figure 30. IruplinacTablets Consumed in Others
Figure 31. Global IruplinacTablets Market: Others (2021-2026) & (Units)
Figure 32. Global IruplinacTablets Sale Market Share by Application (2025)
Figure 33. Global IruplinacTablets Revenue Market Share by Application in 2025
Figure 34. IruplinacTablets Sales by Company in 2025 (Units)
Figure 35. Global IruplinacTablets Sales Market Share by Company in 2025
Figure 36. IruplinacTablets Revenue by Company in 2025 ($ millions)
Figure 37. Global IruplinacTablets Revenue Market Share by Company in 2025
Figure 38. Global IruplinacTablets Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global IruplinacTablets Revenue Market Share by Geographic Region in 2025
Figure 40. Americas IruplinacTablets Sales 2021-2026 (Units)
Figure 41. Americas IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 42. APAC IruplinacTablets Sales 2021-2026 (Units)
Figure 43. APAC IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 44. Europe IruplinacTablets Sales 2021-2026 (Units)
Figure 45. Europe IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa IruplinacTablets Sales 2021-2026 (Units)
Figure 47. Middle East & Africa IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 48. Americas IruplinacTablets Sales Market Share by Country in 2025
Figure 49. Americas IruplinacTablets Revenue Market Share by Country (2021-2026)
Figure 50. Americas IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 51. Americas IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 52. United States IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC IruplinacTablets Sales Market Share by Region in 2025
Figure 57. APAC IruplinacTablets Revenue Market Share by Region (2021-2026)
Figure 58. APAC IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 59. APAC IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 60. China IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. India IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe IruplinacTablets Sales Market Share by Country in 2025
Figure 68. Europe IruplinacTablets Revenue Market Share by Country (2021-2026)
Figure 69. Europe IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 70. Europe IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 71. Germany IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. France IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. UK IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa IruplinacTablets Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 79. Egypt IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of IruplinacTablets in 2026
Figure 85. Manufacturing Process Analysis of IruplinacTablets
Figure 86. Industry Chain Structure of IruplinacTablets
Figure 87. Channels of Distribution
Figure 88. Global IruplinacTablets Sales Market Forecast by Region (2027-2032)
Figure 89. Global IruplinacTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global IruplinacTablets Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global IruplinacTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global IruplinacTablets Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global IruplinacTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IruplinacTablets
Figure 2. IruplinacTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IruplinacTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global IruplinacTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IruplinacTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IruplinacTablets Sales Market Share by Country/Region (2025)
Figure 10. IruplinacTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg / tablet
Figure 12. Product Picture of 60 mg / tablet
Figure 13. Global IruplinacTablets Sales Market Share by Type in 2026
Figure 14. Global IruplinacTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Iruplinalkib Combined With Cabozantinib
Figure 16. Product Picture of Iruplinalkib Combined With Pralsetinib
Figure 17. Global IruplinacTablets Sales Market Share by Combination Therapy in 2026
Figure 18. Global IruplinacTablets Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global IruplinacTablets Sales Market Share by Sales Channel in 2026
Figure 23. Global IruplinacTablets Revenue Market Share by Sales Channel (2021-2026)
Figure 24. IruplinacTablets Consumed in Non-Small Cell Lung Cancer
Figure 25. Global IruplinacTablets Market: Non-Small Cell Lung Cancer (2021-2026) & (Units)
Figure 26. IruplinacTablets Consumed in Medullary Thyroid Carcinoma
Figure 27. Global IruplinacTablets Market: Medullary Thyroid Carcinoma (2021-2026) & (Units)
Figure 28. IruplinacTablets Consumed in Differentiated Thyroid Carcinoma
Figure 29. Global IruplinacTablets Market: Differentiated Thyroid Carcinoma (2021-2026) & (Units)
Figure 30. IruplinacTablets Consumed in Others
Figure 31. Global IruplinacTablets Market: Others (2021-2026) & (Units)
Figure 32. Global IruplinacTablets Sale Market Share by Application (2025)
Figure 33. Global IruplinacTablets Revenue Market Share by Application in 2025
Figure 34. IruplinacTablets Sales by Company in 2025 (Units)
Figure 35. Global IruplinacTablets Sales Market Share by Company in 2025
Figure 36. IruplinacTablets Revenue by Company in 2025 ($ millions)
Figure 37. Global IruplinacTablets Revenue Market Share by Company in 2025
Figure 38. Global IruplinacTablets Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global IruplinacTablets Revenue Market Share by Geographic Region in 2025
Figure 40. Americas IruplinacTablets Sales 2021-2026 (Units)
Figure 41. Americas IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 42. APAC IruplinacTablets Sales 2021-2026 (Units)
Figure 43. APAC IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 44. Europe IruplinacTablets Sales 2021-2026 (Units)
Figure 45. Europe IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa IruplinacTablets Sales 2021-2026 (Units)
Figure 47. Middle East & Africa IruplinacTablets Revenue 2021-2026 ($ millions)
Figure 48. Americas IruplinacTablets Sales Market Share by Country in 2025
Figure 49. Americas IruplinacTablets Revenue Market Share by Country (2021-2026)
Figure 50. Americas IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 51. Americas IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 52. United States IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC IruplinacTablets Sales Market Share by Region in 2025
Figure 57. APAC IruplinacTablets Revenue Market Share by Region (2021-2026)
Figure 58. APAC IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 59. APAC IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 60. China IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. India IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe IruplinacTablets Sales Market Share by Country in 2025
Figure 68. Europe IruplinacTablets Revenue Market Share by Country (2021-2026)
Figure 69. Europe IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 70. Europe IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 71. Germany IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. France IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. UK IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa IruplinacTablets Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa IruplinacTablets Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa IruplinacTablets Sales Market Share by Application (2021-2026)
Figure 79. Egypt IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries IruplinacTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of IruplinacTablets in 2026
Figure 85. Manufacturing Process Analysis of IruplinacTablets
Figure 86. Industry Chain Structure of IruplinacTablets
Figure 87. Channels of Distribution
Figure 88. Global IruplinacTablets Sales Market Forecast by Region (2027-2032)
Figure 89. Global IruplinacTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global IruplinacTablets Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global IruplinacTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global IruplinacTablets Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global IruplinacTablets Revenue Market Share Forecast by Application (2027-2032)
